Michael Gallagher
Affiliations: | Whitehead Institute (MIT), Cambridge, MA, United States |
Google:
"Michael Gallagher"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Diaz-Ortiz ME, Jain N, Gallagher MD, et al. (2023) Testing for Allele-specific Expression from Human Brain Samples. Bio-Protocol. 13: e4832 |
| Diaz-Ortiz ME, Seo Y, Posavi M, et al. (2022) GPNMB confers risk for Parkinson's disease through interaction with α-synuclein. Science (New York, N.Y.). 377: eabk0637 |
| Gallagher MD, Chen-Plotkin AS. (2018) The Post-GWAS Era: From Association to Function. American Journal of Human Genetics. 102: 717-730 |
| Gallagher MD, Posavi M, Huang P, et al. (2017) A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression. American Journal of Human Genetics |
| Cooper CA, Jain N, Gallagher MD, et al. (2017) Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype. Annals of Clinical and Translational Neurology. 4: 15-25 |
| Swanson CR, Li K, Unger TL, et al. (2015) Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 805-12 |
| Gallagher MD, Suh E, Grossman M, et al. (2014) TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathologica. 127: 407-18 |
| Chen-Plotkin AS, Unger TL, Gallagher MD, et al. (2012) TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 11213-27 |